Recipharm Contracted for Commercial Manufacture of ViroPharma's Plenadren
Genetic Engineering News
ViroPharma contracted Recipharm to carry out full commercial-scale manufacture of PlenadrenĀ®, a modified release hydrocortisone drug approved in Europe in November 2011 in Europe for the treatment of adrenal insufficiency in adults.
Recipharm contracted by ViroPharma to complete full commercial manufacture of (press release)

all 2 news articles »